"Mallinckrodt Institute of Radiology (MIR) is a globally recognized center of imaging excellence and the academic radiology department at Washington University School of Medicine in St. Louis. MIR provides a full range of diagnostic and therapeutic patient care services at Barnes-Jewish and St. Louis Children’s hospitals, Barnes-Jewish West County, Missouri Baptist Medical Center, Barnes-Jewish St. Peters and Progress West hospitals, and Siteman Cancer Center, among others. In addition, MIR is an international leader in future-driven education and groundbreaking research that connects health science to health care."

During the past decade, Mallinckrodt Institute of Radiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mallinckrodt Institute of Radiology" #1 sponsor was "Radiation Therapy Oncology Group" with 35 trials, followed by "American College of Radiology Imaging Network" with 5 trials sponsored, "St. Luke's Hospital, Chesterfield, Missouri" with 2 trials sponsored, "AIDS Malignancy Consortium" with 1 trials sponsored and "Alliance for Clinical Trials in Oncology" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mallinckrodt Institute of Radiology" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mallinckrodt Institute of Radiology" are "Head and Neck Cancer" (8 trials), "Prostate Cancer" (7 trials), "Metastatic Cancer" (6 trials), "Lung Cancer" (5 trials) and "Brain and Central Nervous System Tumors" (4 trials). Many other conditions were trialed in "Mallinckrodt Institute of Radiology" in a lesser frequency.

Most popular intervention types in "Mallinckrodt Institute of Radiology" are "Radiation" (33 trials), "Drug" (28 trials), "Procedure" (19 trials), "Biological" (7 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (29 trials), "cisplatin" (8 trials), "conventional surgery" (8 trials), "paclitaxel" (6 trials) and "filgrastim" (5 trials). Other intervention names were less common.

The vast majority of trials in "Mallinckrodt Institute of Radiology" are 38 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mallinckrodt Institute of Radiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Mallinckrodt Institute of Radiology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mallinckrodt Institute of Radiology, 8 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".